FDA Adverse Event Injury Summary report: N

STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

MDR report key: 24153187 · Received January 22, 2026

Report

Report Number
3006630150-2026-00473
Event Type
Injury
Date Received
January 22, 2026
Date of Event
December 27, 2025
Report Date
March 19, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
NHL
UDI-DI
08714729966340
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DEVICE HISTORY RECORD REVIEW: A REVIEW OF THE MANUFACTURING RECORDS ASSOCIATED WITH THESE DEVICES INDICATED THAT THEY WERE SUCCESSFULLY PROCESSED ACCORDING TO REQUIREMENTS. THE DHR DID NOT IDENTIFY ANY MANUFACTURING PROCESS-RELATED NON-CONFORMANCES, SCRAP, OR REWORK PERFORMED DURING PRODUCTION THAT COULD HAVE CAUSED OR CONTRIBUTED TO THIS EVENT. THE DHR REVIEW ENSURES EACH DEVICE MEETS REQUIRED SPECIFICATIONS AND ASSOCIATED TESTING PRIOR TO RELEASE FOR DISTRIBUTION/SALE. LABELING REVIEW: A LABELLING REVIEW WAS PERFORMED, AND IT DID NOT REVEAL ANY ANOMALIES AS IT STATES INFECTION IS A KNOWN RISK WITH THE USE OF DEEP BRAIN STIMULATION (DBS). INVESTIGATION CONCLUSION: THE DEVICES WERE NOT RETURNED AS THEY WERE RETAINED BY THE MEDICAL FACILITY. AS SUCH, PHYSICAL ANALYSIS HAS NOT BEEN CONDUCTED IN OUR LABORATORY. HOWEVER, A LABELING REVIEW WAS CONDUCTED. THIS REVIEW DETERMINED THE REPORTED EVENT OF INFECTION IS A KNOWN RISK ASSOCIATED WITH THE USE OF DEEP BRAIN STIMULATION (DBS) AS DOCUMENTED IN THE INSTRUCTIONS FOR USE (IFU).

Additional Manufacturer Narrative · 0

BLOCK B3 DATE OF EVENT: APPROXIMATELY ONE WEEK BEFORE PATIENTS VISIT TO HOSPITAL - EXACT EVENT DATE IS UNKNOWN. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365DB3216550. MODEL: DB-3216-55. SERIAL: (B)(6). BATCH: 5003972. UDI: (B)(4). PRODUCT FAMILY: DBS-EXTENSION. UPN: M365DB3216550. MODEL: DB-3216-55. SERIAL: (B)(6). BATCH: 5004007. UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) EXPERIENCED AN INFECTION AT THE SITE OF THE LEAD. THE PATIENT WENT TO THE HOSPITAL AND UNDERWENT A REVISION PROCEDURE WHERE THE FULL DBS SYSTEM WAS EXPLANTED. THE PATIENT WAS ADMINISTERED ANTIBIOTICS. THE PATIENT WAS DOING WELL POST OPERATIVELY. THE EXPLANTED DEVICES WERE RETAINED BY THE HOSPITAL AND WERE NOT RETURNED. A CULTURE WAS TAKEN AND RESULTS WERE NEGATIVE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) EXPERIENCED AN INFECTION AT THE SITE OF THE LEAD. THE PATIENT WENT TO THE HOSPITAL AND UNDERWENT A REVISION PROCEDURE WHERE THE FULL DBS SYSTEM WAS EXPLANTED. THE PATIENT WAS ADMINISTERED ANTIBIOTICS. THE PATIENT WAS DOING WELL POST OPERATIVELY. THE EXPLANTED DEVICES WERE RETAINED BY THE HOSPITAL AND WERE NOT RETURNED. A CULTURE WAS TAKEN AND RESULTS WERE NEGATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
213582 STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION CORPORATION DB-2203-45 5005233 08714729966340

Patients

Seq Age Sex Outcome Treatment
1 82 YR Male Required Intervention| H